<DOC>
	<DOCNO>NCT00826644</DOCNO>
	<brief_summary>Belotecan ( Camtobell , CKD-602 , Chong Kun Dang Pharm. , Korea ) new camptothecin derivative , exhibits anticancer effect inhibit topoisomerase I . The investigator randomize prospective multicenter trial Belotecan/Cisplatin versus Etoposide/Cisplatin patient previously untreated , extensive-stage small cell lung cancer . Primary endpoint - assess Response Rate Secondary endpoint - ass Overall response duration , Time progression , Overall survival</brief_summary>
	<brief_title>Trial Belotecan/Cisplatin Chemotherapy Naive Small Cell Lung Cancer Patient</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Small Cell</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Belotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>ECOG Performance status 0~2 ( performance status 2 must stable deterioration previous 2 week ) Histologically cytologically confirm small cell lung cancer Patient without chemotherapy radiotherapy Measurable lesion accord RECIST least one measurable lesion previously irradiate , unless disease progression document site Life expectancy least 3 month Provision write informed consent As judged investigator , evidence severe uncontrolled systemic disease Serum bilirubin great 3 time upper limit reference range ( ULRR ) Aspartate aminotransferase ( AST/SGOT ) alanine aminotransferase ( ALT/SGPT ) great 2.5 time ULN demonstrable liver metastasis ( &gt; 5 time presence liver metastasis ) Evidence significant clinical disorder laboratory find make undesirable subject participate study Pregnancy breastfeed woman ( woman childbearing potential ) . Women childbearing potential must practice acceptable method birth control prevent pregnancy Evidence brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Small cell lung cancer</keyword>
	<keyword>Camptothecin</keyword>
	<keyword>Response rate</keyword>
</DOC>